PDCD1 and neoplasm: For example, it has been hypothesized that anti-PD-1 antibody works largely through tumor-reactive CD8+ cytotoxic T lymphocytes (CD8+-CTLs) within the tumor, as part of TILs, to suppress tumor growth.